Results 271 to 280 of about 35,799 (284)
Some of the next articles are maybe not open access.

Dasatinib-Induced Pulmonary Arterial Hypertension

Canadian Journal of Cardiology, 2019
A 73-year-old woman with chronic myeloid leukemia developed severe pulmonary arterial hypertension (PAH) and pleural effusions after treatment with dasatinib. During workup, partial anomalous pulmonary venous connection and a sinus venosus atrial septal defect were found; these anomalies may have predisposed her to developing this rare and life ...
Evan Orlikow   +2 more
openaire   +3 more sources

Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib

Leukemia, 2022
Yuya Sasaki   +17 more
semanticscholar   +1 more source

Chylothorax secondary to dasatinib

Archivos de Bronconeumología (English Edition), 2020
Virginia Molina   +3 more
openaire   +3 more sources

Src inhibitor dasatinib sensitized gastric cancer cells to cisplatin

Medical Oncology, 2022
Huizhen Wang   +6 more
semanticscholar   +1 more source

The hemorrhage risk of dasatinib therapy

Blood, 2023
Giulia Pontarollo, Christoph Reinhardt
openaire   +2 more sources

Subacute thyroiditis by dasatinib

Medicina Clínica (English Edition), 2020
Cristina Tejera Pérez   +2 more
openaire   +2 more sources

Dasatinib Induced Chylothorax

A39. DRUG RELATED CASE REPORTS, 2019
Ahmad Alratroot   +3 more
openaire   +1 more source

Sorafenib combined with dasatinib therapy inhibits cell viability, migration, and angiogenesis synergistically in hepatocellular carcinoma

Cancer Chemotherapy and Pharmacology, 2021
Chiung-Chi Cheng   +5 more
semanticscholar   +1 more source

M153 DASATINIB THERAPY AND HYPOGAMMAGLOBULINEMIA

Annals of Allergy, Asthma & Immunology, 2021
L. Kaminsky, T. Al-Shaikhly, S. Modi
openaire   +2 more sources

Dasatinib-induced lupus

The Lancet, 2008
Delphine Rea   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy